Lai Gui-Hua, Huang Ai-Lan, Zhao Zhi, Lu Xing-Hao, Zu Wen-Xuan
Department of Human Anatomy, First Affiliated Hospital of Bengbu Medical College, Bengbu 233030, China.E-mail: lailgh198272@ foxmail.com.
Nan Fang Yi Ke Da Xue Xue Bao. 2018 May 20;38(5):505-510. doi: 10.3969/j.issn.1673-4254.2018.05.01.
To investigate the tumor-suppressing effect of microRNA-218 (miR-218) in osteosarcoma (OS) and explore its molecular mechanism.
We examined the expression levels of miR-218 in 68 pairs of OS and adjacent tissue samples using qRT-PCR.Cultured human OS cell line Saos-2 was transfected with miR-218 mimics or anti-miR-218 mimics, and the cell apoptosis was assessed using CCK-8 assay, annexin V-FITC staining and Western blotting.We also analyzed the potential functional targets of miR-218 in Saos-2 cells using luciferase assay, qRT-PCR and Western blotting.
The expression level of miR-218 was lowered by at least 8 folds in OS tissues as compared with the adjacent tissues.In cultured Saos-2 cells, transfection with miR-218 mimics for 24, 36, and 48 h resulted in a significant reduction in the cell viability, while transfection with anti-miR-218 mimics significantly increased the cell viability.The cells transfected with miR-218 mimics showed an obviously enhanced expression of cleaved poly (ADP-ribose) polymerase (C-PARP) as compared with the cells transfected with anti-miR-218 mimics and the control cells.Flow cytometry demonstrated obviously increased apoptosis of the cells following miR-218 mimics transfection.We identified the oncogene B lymphoma mouse Moloney leukemia virus insertion region 1 (BMI-1) as a specific target of miR-218 in Saos-2 cells. BMI-1 expressions at both the mRNA and protein levels were significantly reduced in Saos-2 cells overexpressing miR-218 but increased in the cells with miR-218 knockdown as compared to the control cells.Luciferase reporter assay indicated that miR-218 directly inhibited the expression of BMI-1 binding to its 3'-UTR in OS cells.
miR-218 can promote OS cell apoptosis and plays the role as a tumor suppressor by down-regulating BMI-1.
研究微小RNA-218(miR-218)在骨肉瘤(OS)中的抑瘤作用并探讨其分子机制。
采用qRT-PCR检测68对OS组织及癌旁组织样本中miR-218的表达水平。将人OS细胞系Saos-2用miR-218模拟物或抗miR-218模拟物转染,采用CCK-8法、膜联蛋白V-FITC染色及蛋白质印迹法评估细胞凋亡情况。我们还通过荧光素酶报告基因检测、qRT-PCR及蛋白质印迹法分析miR-218在Saos-2细胞中的潜在功能靶点。
与癌旁组织相比,OS组织中miR-218的表达水平降低了至少8倍。在培养的Saos-2细胞中,用miR-218模拟物转染24、36和48小时后,细胞活力显著降低,而用抗miR-218模拟物转染则显著提高细胞活力。与用抗miR-218模拟物转染的细胞及对照细胞相比,用miR-218模拟物转染的细胞中裂解的聚(ADP-核糖)聚合酶(C-PARP)的表达明显增强。流式细胞术显示miR-218模拟物转染后细胞凋亡明显增加。我们确定原癌基因B淋巴瘤小鼠莫洛尼白血病病毒插入区1(BMI-1)是miR-218在Saos-2细胞中的特异性靶点。与对照细胞相比,过表达miR-218的Saos-2细胞中BMI-1的mRNA和蛋白水平均显著降低,而在miR-218敲低的细胞中则升高。荧光素酶报告基因检测表明,miR- 在OS细胞中直接抑制与BMI-1 3'-UTR结合的BMI-1的表达。
miR-218可促进OS细胞凋亡,并通过下调BMI-1发挥肿瘤抑制作用。